Our retrospective analysis identifies thrombocytopenia at diagnosis, BCR::ABL1(+), and suboptimal early treatment response [persistent minimal residual disease (MRD)] as independent predictors of relapse. The gene discussed is BCR; the disease is Thrombocytopenia.